Drug Trial Radar · NCT02927249
Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy
Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
3,021
Actual
Start
Jan 6, 2017
Primary completion
Dec 13, 2021
Study completion Feb 15, 2023
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group
- First posted
- Oct 7, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 69 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies how well aspirin works in preventing the cancer from coming back (recurrence) in patients with human epidermal growth factor receptor 2 (HER2) negative breast cancer after chemotherapy, surgery, and/or radiation therapy. Aspirin is a drug that reduces pain, fever, inflammation, and blood clotting. It is also being studied in cancer prevention. Giving aspirin may reduce the rate of cancer recurrence in patients with breast cancer.
Conditions
- Node Positive HER2 Negative Breast Cancer
Interventions
PlaceboOther
Given PO
AspirinDrug
Given PO
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Invasive Disease-free Survival (iDFS)Time frame: 5 years
Locations
1,452 sites in 4 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Southern Cancer Center PC-Daphne
Daphne, Alabama
Southern Cancer Center PC-Mobile
Mobile, Alabama
Southern Cancer Center PC-Providence
Mobile, Alabama
Southern Cancer Center PC-Springhill
Mobile, Alabama
Anchorage Associates in Radiation Medicine
Anchorage, Alaska
Anchorage Radiation Therapy Center
Anchorage, Alaska
Alaska Breast Care and Surgery LLC
Anchorage, Alaska
Alaska Oncology and Hematology LLC
Anchorage, Alaska
Alaska Women's Cancer Care
Anchorage, Alaska
Anchorage Oncology Centre
Anchorage, Alaska
Katmai Oncology Group
Anchorage, Alaska
Providence Alaska Medical Center
Anchorage, Alaska
Fairbanks Memorial Hospital
Fairbanks, Alaska
Arizona Breast Cancer Specialists-Gilbert
Gilbert, Arizona
Virginia G Piper Cancer Care-Glendale
Glendale, Arizona
Kingman Regional Medical Center
Kingman, Arizona
Arizona Center for Cancer Care-Peoria
Peoria, Arizona
Cancer Center at Saint Joseph's
Phoenix, Arizona
Arizona Breast Cancer Specialists-Phoenix
Phoenix, Arizona
Arizona Breast Cancer Specialists
Scottsdale, Arizona
Arizona Breast Cancer Specialists-Scottsdale
Scottsdale, Arizona
Virginia G Piper Cancer Care-Del Camino
Scottsdale, Arizona
Arizona Center for Cancer Care-Surprise
Surprise, Arizona
Highlands Oncology Group PA - Fayetteville
Fayetteville, Arkansas
Mercy Hospital Fort Smith
Fort Smith, Arkansas
CHI Saint Vincent Cancer Center Hot Springs
Hot Springs, Arkansas
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas
Highlands Oncology Group
Rogers, Arkansas
Highlands Oncology Group - Springdale
Springdale, Arkansas
Kaiser Permanente-Anaheim
Anaheim, California
Kaiser Permanente-Deer Valley Medical Center
Antioch, California
Mission Hope Medical Oncology - Arroyo Grande
Arroyo Grande, California
PCR Oncology
Arroyo Grande, California
Sutter Auburn Faith Hospital
Auburn, California
Sutter Cancer Centers Radiation Oncology Services-Auburn
Auburn, California
AIS Cancer Center at San Joaquin Community Hospital
Bakersfield, California
Kaiser Permanente-Baldwin Park
Baldwin Park, California
Kaiser Permanente-Bellflower
Bellflower, California
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Showing 40 of 1,452 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.